Central nervous system (CNS) tumours in neonates are relatively rare and present differently when compared with those occurring later in childhood in terms of aetiology, clinical features, location, histology and prognosis. The clinical presentation is extremely variable. Even i...
Central nervous system (CNS) tumors are challenging due to its broad spectrum of aggressiveness, dismal prognosis, and the paucity of treatment alternatives. Gliomas encompass approximately 80 % of all primary malignant brain tumors. The standard approach for gliomas is usually based on expensive multi...
主要参考文献: [1]WHO Classification of Tumours • 5th Edition Central Nervous System Tumours [2] Gembruch O, Junker A, Monninghoff C,et al. Liponeurocytoma: systematic review of a rare entity. World Neurosurg. [3]Hassoun J, Soylemezoglu F, Gambarelli D, et al. Central neurocytoma: ...
Biegel JA, Tan L, Zhang F et al (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhaboid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461–3467 PubMedCASGoogle Scholar Blaney SM, Kun LE, Hunter J et al (2006) Tumors of the...
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK: WHO classification of tumours of the central nervous system. 2007, Lyon: IARC Google Scholar Rousseau A, Mokhtari K, Duyckaerts C: The 2007 WHO classification of tumors of the central nervous system - what has changed?. Curr Opin Neurol. 2008...
To present a case series of de-novo central nervous system (CNS) tumours in adults with intellectual disabilities (ID). Three cases of de-novo brain tumours in adults with (ID) were identified. The casenotes were reviewed and compared with the current evidence base of CNS tumours. Three wom...
3.Clinical Analysis of Primary Pediatric Central Nervous System Tumors;儿童原发性中枢神经系统肿瘤的临床分析 4.To Learn the 4~(th)Edition(Published in 2007)of"WHO Classification of Tumours of the Central Nervous System"学习2007年版“WHO中枢神经系统肿瘤的病理分类” ...
NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors 来自 EBSCO 喜欢 0 阅读量: 11 作者:EE Kim,CK Park,SK Kim,JH Phi,SH Paek,JY Choi,HJ Kang,JH Lee,JK Won,H Yun 摘要: Background Neurotrophic tropomyosin receptor kinase (NTRK) ...
Here we present a comprehensive approach for the DNA methylation-based classification of central nervous system tumours across all entities and age groups, and demonstrate its application in a routine diagnostic setting. We show that the availability of this method may have a substantial impact on ...
Central nervous system (CNS) tumours are heterogeneous. The terms malignant and benign are not very useful because: Even small slowly growing tumours can cause severe symptoms because the brain is enclosed in a rigid skull. Surgery can be difficult because many tumours are infiltrating and often ...